You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site


Go back


At GSK we have a long heritage and expertise in anti-infectives going back 40 years. We are one of the few pharmaceutical companies committed to delivering new antibacterials. We are also committed towards appropriate usage of antibiotics.
Here you will find information about our anti-infectives portfolio, as well as resources and news to support healthcare professionals working to treat infections in adults and children.

Our Legacy

Our products


Augmentin is indicated for the short-term treatment of infections caused by susceptible bacteria and has a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital.                            [2-6]

Find out more

(cefuroxime axetil)

Zinnat is indicated for the treatment of a wide range of community-acquired infections caused by susceptible bacteria. [7] [8]

Find out more